Navigation Links
PharmAthene Reports Year-End 2007 Financial Results

ssociated with obtaining regulatory approvals, unforeseen technical difficulties, dependencies on certain customers or products, market acceptance and competition, ability to receive grant and contract revenue and procurement funding, ability to identify any additional strategic acquisitions or other opportunities to accelerate growth, cash at the end of the year, as well as other risks described in the Company's filings with the Securities and Exchange Commission, in conference calls and in other communications.



December 31,

2007 2006

Current assets:

Cash and cash equivalents $40,582,643 $5,112,212

Short-term investments 12,153,945 -

Accounts receivable 5,245,763 1,455,538

Prepaid expenses 476,511 877,621

Other current assets 15,783 104,772

Total current assets 58,474,645 7,550,143

Property and equipment, net 6,571,024 5,230,212

Patents, net 1,312,991 1,246,236

Other long term assets 183,588 153,336

Deferred costs 68,884 587,577

Total assets $66,611,132 $14,767,504



Current Liabilities:

Accounts payable $1,393,664 $839,120

Accrued expenses and other liabilities 3,602,886 1,587,017

Notes pay

SOURCE PharmAthene, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related biology technology :

1. Hearing Scheduled in the Delaware Court of Chancery for August 27, 2007 to Establish the Valid Approval and Consummation of the Merger Between PharmAthene, Inc. and Healthcare Acquisition Corp.
2. Proceedings to Affirm Merger Between PharmAthene and Healthcare Acquisition Corp Initiated in Delaware Chancery Court
3. PharmAthene Named as Contractor in $13.9 Million Award Notice Published by the Department of Health and Human Services
4. Delaware Court Denies Motion by SIGA Technologies Seeking to Dismiss PharmAthenes Legal Action in Breach of Contract Lawsuit Against SIGA
5. PharmAthene to Present at the BIO CEO & Investor Conference 2008
6. PharmAthene Enhances Executive Leadership Team and Appoints Joan Fusco, Ph.D. Senior Vice President of Operations
7. PharmAthene Completes Pharmacokinetic Studies of Protexia(R); Program on Target for IND Filing in 2008
8. PharmAthene to Present at the Cowen and Company 28th Annual Health Care Conference
9. PharmAthene Signs Definitive Agreement to Acquire Biodefense Vaccines Business From Avecia
10. PharmAthene to Delay Release of Full Year 2007 Financial Results
11. PharmAthene Year-End 2007 Earnings Conference Call and Webcast Scheduled for Monday, March 31, 2008
Post Your Comments:
(Date:9/18/2014)... 18, 2014 About POCT ... outside a clinical laboratory. It helps in making ... treatments and medication. POCT is gaining popularity due ... diseases such as diabetes, heart disease, and obesity. ... are standardized to minimize errors during the diagnosis ...
(Date:9/18/2014)... , September 18, 2014 ... ( ) has announced the ... - Global Strategic Business Report" ... ,This report analyzes the worldwide ... Million by the following Product Segments: ...
(Date:9/18/2014)... , Sept. 18, 2014 Research ... the "Global N-acetylcysteine Industry Report 2014" ... Global N-acetylcysteine Industry Report 2014 is a professional ... the global N-acetylcysteine industry. The report ... definitions, classifications, applications and industry chain structure. The ...
(Date:9/18/2014)... LOUIS , Sept. 18, 2014  U.S. biotech ... by signing an exclusive license for technology developed by ... control gene expression in plants, including for applications in ... The technology was developed under the ... officer at Kultevat and former president of the Danforth ...
Breaking Biology Technology:POCT Market in China 2014-2018 2Biocompatible Materials - Global Strategic Business Report 2014 2Biocompatible Materials - Global Strategic Business Report 2014 3Global N-acetylcysteine Industry Report 2014 2Kultevat obtains license of gene switch technology 2
... Sept. 13 Allos,Therapeutics, Inc. (Nasdaq: ALTH ... commercialization of small molecule therapeutics for,the treatment of ... and,CEO, will present a corporate overview at the ... The Company,s presentation will take place at ...
... a world leader in,the rapidly evolving field of cancer ... H. M. Lindenbergh as Chairman of its,Supervisory Board. ... board of ING,Group N.V.. Currently, Mr. Lindenbergh is chairman ... member of the Royal Numico, Petroplus,International and Gamma Holding. ...
... ADVENTRX Pharmaceuticals,Inc. (Amex: ANX ), ... commercializing proprietary product candidates for the treatment,of ... Evan M. Levine,ADVENTRX,s chief executive officer, is ... Annual Growth Conference on Wednesday,September 19th, 2007 ...
Cached Biology Technology:Allos Therapeutics to Present at the 2007 UBS Global Life Sciences Conference 2Agendia BV Appoints Mr. Hessel Lindenbergh as Chairman of its Supervisory Board 2ADVENTRX Pharmaceuticals to Present at the ThinkEquity Partners' Fifth Annual Growth Conference 2
(Date:9/19/2014)... -- Nxt-ID, Inc. (Nasdaq: NXTD and NXTDW) ("Nxt-ID" ... m-commerce market, updates the "Wocket in Your Pocket" celebrity ad campaign, ... middleweight weight classes, Vinny Pazienza (PAZ). ... of Thrones actor Ciaran Hinds and Sons ... Katey Sagal have been cast in Bleed for This ...
(Date:9/18/2014)... PULLMAN, Wash. - Washington State University researchers have developed ... sediment to power waste cleanup in rural areas. ... lead to an inexpensive and quick way to clean ... treatment plants while reducing pollution. , Professor Haluk ... College of Engineering and Architecture discuss the system in ...
(Date:9/18/2014)... located deep in the primitive brainstem has revealed how ... Harvard School of Medicine and the University at Buffalo ... the second "sleep node" identified in the mammalian brain ... to produce deep sleep. , Published online in August ... fully half of all of the brain,s sleep-promoting activity ...
Breaking Biology News(10 mins):NXT-ID's Vinny Paz Celebrity Ad Wocket Update: Katey Sagal and Ciaran Hinds Attached to His Upcoming Movie 2NXT-ID's Vinny Paz Celebrity Ad Wocket Update: Katey Sagal and Ciaran Hinds Attached to His Upcoming Movie 3Researchers develop unique waste cleanup for rural areas 2No sedative necessary: Scientists discover new 'sleep node' in the brain 2
... not just be helping digest food but also could be ... other organs, like the liver, according to research published this ... offer new understanding of the symbiotic relationship between humans and ... impact overall health. "The gut microbiota enhances the host,s ...
... of Medicine researchers have identified two genes associated with ... effective treatments for excessive alcohol drinking. The scientists found ... and toll-like receptor 4 (TLR4), "caused profound reduction" of ... been bred and trained to drink excessively. The study ...
... America have been awarded Leopold Leadership Fellowships for ... Institute for the Environment, the Leopold Leadership Program ... make their knowledge accessible to decision makers. ... mid-career academic environmental researchers as fellows. They receive ...
Cached Biology News:Gut bacteria can control organ functions 2University of Maryland School of Medicine study identifies genes associated with binge drinking 2University of Maryland School of Medicine study identifies genes associated with binge drinking 3University of Maryland School of Medicine study identifies genes associated with binge drinking 420 researchers selected as 2011 Leopold Leadership Fellows 220 researchers selected as 2011 Leopold Leadership Fellows 320 researchers selected as 2011 Leopold Leadership Fellows 4
... WesternBreeze Immunodetection Kits are designed ... immobilized on nitrocellulose or PVDF membranes. ... (except membranes and primary antibodies), the ... both optimizing your protocol and getting ...
... L1 Cell Adhesion Molecule ... Xq28, is involved in three distinct conditions: ... Sylvius); 2) MASA (mental retardation, aphasia, shuffling ... paraplegia). Immunogen: Homogenous ...
Immunogen: C terminus [VQLKRSKNDSKPYC] of cardiac elav-type RNA-binding protein (ETR-3) Storage: -20 C, Avoid Freeze/Thaw Cycles...
... Formulation: 50mM Tris-HCl, pH 7.5, ... PMSF, 1mM benzamidine, 0.1% 2-mercaptoethanol ... (Protein Phosphatase 2A1) partially purified ... precipitation, QSepharose,amino-hexyl agarose, Superdex 200, ...
Biology Products: